Patents Assigned to Aratana Therapeutics NV
  • Publication number: 20150352118
    Abstract: The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.
    Type: Application
    Filed: August 17, 2015
    Publication date: December 10, 2015
    Applicant: ARATANA THERAPEUTICS NV
    Inventors: Nesya GORIS, Johan NEYTS, Erwin BLOMSMA, Stefaan WERA, Ainola BILLIET, Joeri AUWERX, Veerle DEBEURME, Maryline ROE, Pascal PUIG
  • Patent number: 9107943
    Abstract: The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: August 18, 2015
    Assignee: ARATANA THERAPEUTICS NV
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Maryline Roe, Pascal Puig
  • Patent number: 9040699
    Abstract: The present invention relates to the preparation of cyclopropane derivatives, in particular 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-4,8-dihydro-1H-purin-6-one, especially via the [(1S,7R)-4-phenyl-3,5-dioxabicyclo[5.1.0]octan-1-yl]methanol intermediate.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: May 26, 2015
    Assignee: Aratana Therapeutics NV
    Inventors: Eleonora Kiss, Erwin Blomsma, Serge De Bruijn, E. J. N. Remy Litjens
  • Publication number: 20150098904
    Abstract: The present invention relates to an eye-drop composition comprising 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one, and the use thereof for the diagnosis and treatment of herpetic eye infections in companion animals.
    Type: Application
    Filed: January 20, 2012
    Publication date: April 9, 2015
    Applicant: ARATANA THERAPEUTICS NV
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Maryline Roe, Pascal Puig
  • Publication number: 20150051394
    Abstract: The present invention relates to the preparation of cyclopropane derivatives, in particular 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-4,8-dihydro-1H-purin-6-one, especially via the [(1S,7R)-4-phenyl-3,5-dioxabicyclo[5.1.0]octan-1-yl]methanol intermediate.
    Type: Application
    Filed: November 10, 2011
    Publication date: February 19, 2015
    Applicant: ARATANA THERAPEUTICS NV
    Inventors: Eleonora Kiss, Erwin Blomsma, Serge De Bruijn, E.J.N. Remy Litjens
  • Publication number: 20150018427
    Abstract: The present invention relates to compounds for use in a method for the treatment or prevention of parvovirus infections in humans and warm-blooded animals, including feline panleukopenia virus (FPV) infections in felids, canine parvovirus type 2 (CPV-2) infections in canines, minute virus of mice (MVM) infections in mice and B19 parvovirus infections in humans.
    Type: Application
    Filed: February 22, 2013
    Publication date: January 15, 2015
    Applicant: Aratana Therapeutics NV
    Inventors: Nesya Goris, Johan Neyts, Erwin Blomsma, Stefaan Wera, Jérôme Villers, Ainola Billiet, Joeri Auwerx, Veerle Debeurme, Eleonora Kiss, Chloë Swinnen